Efficacy of autologous bone marrow concentrate for knee osteoarthritis with and without adipose graft

Christopher Centeno, John Pitts, Hasan Al-Sayegh, Michael Freeman, Christopher Centeno, John Pitts, Hasan Al-Sayegh, Michael Freeman

Abstract

Introduction: We investigated the use of autologous bone marrow concentrate (BMC) with and without an adipose graft, for treatment of knee osteoarthritis (OA).

Methods: Treatment registry data for patients who underwent BMC procedures with and without an adipose graft were analyzed. Pre- and posttreatment outcomes of interest included the lower extremity functional scale (LEFS), the numerical pain scale (NPS), and a subjective percentage improvement rating. Multivariate analyses were performed to examine the effects of treatment type adjusting for potential confounding factors. The frequency and type of adverse events (AE) were also examined.

Results: 840 procedures were performed, 616 without and 224 with adipose graft. The mean LEFS score increased by 7.9 and 9.8 in the two groups (out of 80), respectively, and the mean NPS score decreased from 4 to 2.6 and from 4.3 to 3 in the two groups, respectively. AE rates were 6% and 8.9% in the two groups, respectively. Although pre- and posttreatment improvements were statistically significant, the differences between the groups were not.

Conclusion: BMC injections for knee OA showed encouraging outcomes and a low rate of AEs. Addition of an adipose graft to the BMC did not provide a detectible benefit over BMC alone.

References

    1. Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis and Rheumatism. 2008;58(1):26–35.
    1. Weinstein AM, Rome BN, Reichmann WM, et al. Estimating the burden of total knee replacement in the United States. The Journal of Bone and Joint Surgery. 2013;95(5):385–392.
    1. Insall JN. Historical Development, classification, and characteristics of knee prostheses. In: Insall JN, editor. Surgery of the Knee. 2nd edition. New York, NY, USA: Churchill Livingstone; 1993.
    1. Javad Mortazavi SM, Kakli H, Bican O, Moussouttas M, Parvizi J, Rothman RH. Perioperative stroke after total joint arthroplasty: prevalence, predictors, and outcome. Journal of Bone and Joint Surgery A. 2010;92(11):2095–2101.
    1. Morris MJ, Molli RG, Berend KR, Lombardi AV. Mortality and perioperative complications after unicompartmental knee arthroplasty. Knee. 2013;20(3):218–220.
    1. Lalmohamed A, Vestergaard P, Cooper C, et al. Timing of stroke in patients undergoing total hip replacement and matched controls: a nationwide cohort study. Stroke. 2012;43(12):3225–3229.
    1. Lalmohamed A, Vestergaard P, Klop C, et al. Timing of acute myocardial infarction in patients undergoing total hip or knee replacement: a nationwide cohort study. Archives of Internal Medicine. 2012;172(16):1229–1235.
    1. Pinto PR, McIntyre T, Ferrero R, Araújo-Soares V, Almeida A. Persistent pain after total knee or hip arthroplasty: differential study of prevalence, nature, and impact. Journal of Pain Research. 2013;6:691–703.
    1. Benke M, Shaffer B. Viscosupplementation treatment of arthritis pain. Current Pain and Headache Reports. 2009;13(6):440–446.
    1. Cianflocco AJ. Viscosupplementation in patients with osteoarthritis of the knee. Postgraduate Medicine. 2013;125(1):97–105.
    1. Khoshbin A, Leroux T, Wasserstein D, et al. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis. Arthroscopy. 2013;29(12):2037–2048.
    1. Say F, Gürler D, Yener K, Bülbül M, Malkoc M. Platelet-rich plasma injection is more effective than hyaluronic acid in the treatment of knee osteoarthritis. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca. 2013;80(4):278–283.
    1. Kon E, Filardo G, Di Martino A, Marcacci M. Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surgery, Sports Traumatology, Arthroscopy. 2011;19(4):516–527.
    1. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–147.
    1. Lange C, Schroeder J, Lioznov MV, Zander AR. High-potential human mesenchymal stem cells. Stem Cells and Development. 2005;14(1):70–80.
    1. Autologous mesenchymal stem cells for treating knee osteoarthritis. Managed Care. 2013;22(8):15–16.
    1. Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician. 2008;11(3):343–353.
    1. Centeno CJ. Clinical challenges and opportunities of mesenchymal stem cells in musculoskeletal medicine. PM&R. 2014;6(1):70–77.
    1. Qi Y, Feng G, Yan W. Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis. Molecular Biology Reports. 2012;39(5):5683–5689.
    1. Huang JI, Zuk PA, Jones NF, et al. Chondrogenic potential of multipotential cells from human adipose tissue. Plastic and Reconstructive Surgery. 2004;113(2):585–594.
    1. Pak J. Autologous adipose tissue-derived stem cells induce persistent bone-like tissue in osteonecrotic femoral heads. Pain Physician. 2012;15(1):75–85.
    1. Casteilla L, Planat-Benard V, Laharrague P, Cousin B. Adipose-derived stromal cells: their identity and uses in clinical trials, an update. World Journal of Stem Cells. 2011;3(4):25–33.
    1. Desando G, Cavallo C, Sartoni F, et al. Intra-articular delivery of adipose derived stromal cells attenuates osteoarthritis progression in an experimental rabbit model. Arthritis Research and Therapy. 2013;15(1, article R22)
    1. Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D. Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells. Medical Hypotheses. 2008;71(6):900–908.
    1. Centeno CJ, Schultz JR, Cheever M, et al. Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Current Stem Cell Research and Therapy. 2011;6(4):368–378.
    1. Centeno CJ, Schultz JR, Cheever M, Robinson B, Freeman M, Marasco W. Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Current Stem Cell Research and Therapy. 2010;5(1):81–93.
    1. Centeno CJ, Schultz JR, Cheever M, Freeman M, Robinson B, Faulkner S. A Case Series of Percutaneeous Treatment of Non-Union Fractures with Autologous, Culture Expanded, Bone Marrow Dervied, Mesenchymal Stem Cells and Platelet Lysate. Bioengineering & Biomedical Science, 2011.
    1. J. Centeno C, D. Freeman M. Percutaneous injection of autologous, culture-expanded mesenchymal stem cells into carpometacarpal hand joints: a case series with an untreated comparison group. Wiener Medizinische Wochenschrift. 2013;164(5-6):83–87.
    1. U.S. Department of Health and Human Services. Guidance for Clinical Investigators, Sponsors, and IRBs Adverse Event Reporting to IRBs—Improving Human Subject Protection. Office of the Commissioner, the Center for Drug Evaluation and Research (CDER), the Center for Biologics Evaluation and Research (CBER), the Center for Devices and Radiological health (CDRH), and the Good CLinical Practice Program (GCPP) at the Food and Drug Administration; 2009.
    1. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Annals of the Rheumatic Diseases. 1957;16(4):494–502.
    1. Sowers M, Karvonen-Gutierrez CA, Jacobson JA, Jiang Y, Yosef M. Associations of anatomical measures from MRI with radiographically defined knee osteoarthritis score, pain, and physical functioning. Journal of Bone and Joint Surgery A. 2011;93(3):241–251.
    1. Bagley SC, White H, Golomb BA. Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain. Journal of Clinical Epidemiology. 2001;54(10):979–985.
    1. Lewis FI, Ward MP. Improving epidemiologic data analyses through multivariate regression modelling. Emerging Themes in Epidemiology. 2013;10(1, article 4)
    1. Binkley JM, Stratford PW, Lott SA, Riddle DL. The Lower Extremity Functional Scale (LEFS): scale development, measurement properties, and clinical application. Physical Therapy. 1999;79(4):371–383.
    1. Kelly AM. The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emergency Medicine Journal. 2001;18(3):205–207.
    1. SAS 9.4 Software. Cary, NC, USA: SAS Institute Inc; 2014.
    1. Chen MR, Dragoo JL. The effect of nonsteroidal anti-inflammatory drugs on tissue healing. Knee Surgery, Sports Traumatology, Arthroscopy. 2013;21(3):540–549.
    1. Wiggins ME, Fadale PD, Barrach H, Ehrlich MG, Walsh WR. Healing characteristics of a type I collagenous structure treated with corticosteroids. The American Journal of Sports Medicine. 1994;22(2):279–288.
    1. Tsai W, Hsu C, Chen CPC, Chen MJL, Lin M, Pang JS. Ibuprofen inhibition of tendon cell migration and down-regulation of paxillin expression. Journal of Orthopaedic Research. 2006;24(3):551–558.
    1. Tsai W-C, Tang F-T, Wong M-K, Pang J-HS. Inhibition of tendon cell migration by dexamethasone is correlated with reduced alpha-smooth muscle actin gene expression: a potential mechanism of delayed tendon healing. Journal of Orthopaedic Research. 2003;21(2):265–271.
    1. Randelli P, Randelli F, Cabitza P, Vaienti L. The effects of COX-2 anti-inflammatory drugs on soft tissue healing: a review of the literature. Journal of Biological Regulators and Homeostatic Agents. 2010;24(2):107–114.
    1. Goyal D, Keyhani S, Lee EH, Hui JH. Evidence-based status of microfracture technique: a systematic review of level I and II studies. Arthroscopy. 2013;29(9):1579–1588.
    1. Moradi B, Schönit E, Nierhoff C, et al. First-generation autologous chondrocyte implantation in patients with cartilage defects of the knee: 7 to 14 years' clinical and magnetic resonance imaging follow-up evaluation. Arthroscopy. 2012;28(12):1851–1861.
    1. Behery OA, Harris JD, Karnes JM, Siston RA, Flanigan DC. Factors influencing the outcome of autologous chondrocyte implantation: a systematic review. Journal of Knee Surgery. 2013;26(3):203–211.
    1. Liebs TR, Herzberg W, Roth-Kroeger AM, Rüther W, Hassenpflug J. Women recover faster than men after standard knee arthroplasty. Clinical Orthopaedics and Related Research. 2011;469(10):2855–2865.
    1. MacDonald SJ, Charron KD, Bourne RB, Naudie DD, McCalden RW, Rorabeck CH. The John Insall award: gender-specific total knee replacement: prospectively collected clinical outcomes. Clinical Orthopaedics and Related Research. 2008;466(11):2612–2616.
    1. Santaguida PL, Hawker GA, Hudak PL, et al. Patient characteristics affecting the prognosis of total hip and knee joint arthroplasty: a systematic review. Canadian Journal of Surgery. 2008;51(6):428–436.
    1. McElroy MJ, Pivec R, Issa K, Harwin SF, Mont MA. The effects of obesity and morbid obesity on outcomes in TKA. The Journal of Knee Surgery. 2013;26(2):83–88.
    1. Samson AJ, Mercer GE, Campbell DG. Total knee replacement in the morbidly obese: a literature review. ANZ Journal of Surgery. 2010;80(9):595–599.
    1. Sridhar MS, Jarrett CD, Xerogeanes JW, Labib SA. Obesity and symptomatic osteoarthritis of the knee. Journal of Bone and Joint Surgery B. 2012;94(4):433–440.
    1. Gillespie GN, Porteous AJ. Obesity and knee arthroplasty. Knee. 2007;14(2):81–86.
    1. Amin AK, Patton JT, Cook RE, Brenkel IJ. Does obesity influence the clinical outcome at five years following total knee replacement for osteoarthritis? Journal of Bone and Joint Surgery B. 2006;88(3):335–340.
    1. Tynan GA, Hearnden CH, Oleszycka E, et al. Endogenous oils derived from human adipocytes are potent adjuvants that promote IL-1α-dependent inflammation. Diabetes. 2014;63(6):2037–2050.
    1. Belmont PJ, Jr., Goodman GP, Waterman BR, Bader JO, Schoenfeld AJ. Thirty-day postoperative complications and mortality following total knee arthroplasty: incidence and risk factors among a national sample of 15,321 patients. Journal of Bone and Joint Surgery A. 2014;96(1):20–26.
    1. Ward RA, Brier ME. Retrospective analyses of large medical databases: what do they tell us? Journal of the American Society of Nephrology. 1999;10(2):429–432.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere